MAPK7 and Parkinson disease: Further, we also verified that the expression of GRID2, PADI4, RIPK2, CUL4B, BCL6, MRPS31, GPI, and MAP 2 K1 were both significantly increased, and levels of MAPK, ELAVL1, RAB14, KLF9, ARF1, ARFGAP1, ATG7, ABCA7, SFT2D2, E2F2, MAPK7, and UHRF1 were both significantly decreased in PD.